Lollar P
Division of Hematology and Oncology, Emory University School of Medicine, Atlanta, Georgia.
Mayo Clin Proc. 1991 May;66(5):524-34. doi: 10.1016/s0025-6196(12)62395-7.
Factor VIII (FVIII) and von Willebrand factor (vWF) are plasma glycoproteins that circulate as a tightly associated complex. Because they tend to copurify during procedures designed to isolate the biologic activities associated with them, their identity as distinct entities became unequivocally established only during the past 10 years. Improved procedures for the isolation of FVIII, the deduction of the amino acid sequences of FVIII and vWF by using molecular cloning techniques and by direct sequencing, and the use of a variety of biophysical and immunochemical techniques have enhanced the understanding of the FVIII-vWF association. Each subunit of multimeric vWF potentially can bind a single heterodimeric FVIII molecule, although in vivo most of these binding sites are empty. The binding of FVIII to vWF is primarily, if not exclusively, mediated by the light chain of FVIII to the amino-terminal region of the vWF subunit. Cleavage of a fragment from the amino-terminal region of the FVIII light chain by thrombin results in rapid dissociation of the FVIII-vWF complex, a process that apparently is necessary for development of procoagulant activity. Whether this cleavage is needed for the activation of FVIII in the absence of vWF is controversial. The extracellular association of FVIII with vWF may be necessary for efficient secretion of FVIII from its cell of origin. The thermodynamics, kinetics, and nature of the molecular contacts involved in the interaction have not been studied. The association of FVIII with vWF prolongs the lifetime of FVIII in plasma. Whether the FVIII-vWF interaction has other functional roles, such as restricting the location of procoagulant activity, remains unknown.
凝血因子VIII(FVIII)和血管性血友病因子(vWF)是血浆糖蛋白,它们以紧密结合的复合物形式循环。由于在旨在分离与其相关的生物学活性的过程中它们往往会共同纯化,因此直到过去10年它们作为不同实体的身份才得以明确确立。用于分离FVIII的改进方法、通过分子克隆技术和直接测序推导FVIII和vWF的氨基酸序列,以及使用各种生物物理和免疫化学技术,都增进了对FVIII-vWF结合的理解。多聚体vWF的每个亚基都有可能结合一个异二聚体FVIII分子,尽管在体内这些结合位点大多是空的。FVIII与vWF的结合主要(如果不是唯一的话)是由FVIII的轻链介导至vWF亚基的氨基末端区域。凝血酶从FVIII轻链的氨基末端区域切割下一个片段会导致FVIII-vWF复合物迅速解离,这一过程显然是促凝活性发展所必需的。在没有vWF的情况下这种切割是否是FVIII激活所必需的存在争议。FVIII与vWF在细胞外的结合对于FVIII从其起源细胞的有效分泌可能是必要的。参与相互作用的分子接触的热力学、动力学和性质尚未得到研究。FVIII与vWF的结合延长了FVIII在血浆中的寿命。FVIII-vWF相互作用是否具有其他功能作用,例如限制促凝活性的位置,仍然未知。